2023-04-012024-03-312024-03-31false07598573EVERGREEN SURGERY LIMITED2024-11-07iso4217:GBPxbrli:pure075985732023-04-01075985732024-03-31075985732023-04-012024-03-31075985732022-04-01075985732023-03-31075985732022-04-012023-03-3107598573bus:SmallEntities2023-04-012024-03-3107598573bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3107598573bus:AbridgedAccounts2023-04-012024-03-3107598573bus:PrivateLimitedCompanyLtd2023-04-012024-03-3107598573core:WithinOneYear2024-03-3107598573core:AfterOneYear2024-03-3107598573core:WithinOneYear2023-03-3107598573core:AfterOneYear2023-03-3107598573core:ShareCapital2024-03-3107598573core:SharePremium2024-03-3107598573core:RevaluationReserve2024-03-3107598573core:OtherReservesSubtotal2024-03-3107598573core:RetainedEarningsAccumulatedLosses2024-03-3107598573core:ShareCapital2023-03-3107598573core:SharePremium2023-03-3107598573core:RevaluationReserve2023-03-3107598573core:OtherReservesSubtotal2023-03-3107598573core:RetainedEarningsAccumulatedLosses2023-03-3107598573core:LandBuildings2024-03-3107598573core:PlantMachinery2024-03-3107598573core:Vehicles2024-03-3107598573core:FurnitureFittings2024-03-3107598573core:OfficeEquipment2024-03-3107598573core:NetGoodwill2024-03-3107598573core:IntangibleAssetsOtherThanGoodwill2024-03-3107598573core:ListedExchangeTraded2024-03-3107598573core:UnlistedNon-exchangeTraded2024-03-3107598573core:LandBuildings2023-03-3107598573core:PlantMachinery2023-03-3107598573core:Vehicles2023-03-3107598573core:FurnitureFittings2023-03-3107598573core:OfficeEquipment2023-03-3107598573core:NetGoodwill2023-03-3107598573core:IntangibleAssetsOtherThanGoodwill2023-03-3107598573core:ListedExchangeTraded2023-03-3107598573core:UnlistedNon-exchangeTraded2023-03-3107598573core:LandBuildings2023-04-012024-03-3107598573core:PlantMachinery2023-04-012024-03-3107598573core:Vehicles2023-04-012024-03-3107598573core:FurnitureFittings2023-04-012024-03-3107598573core:OfficeEquipment2023-04-012024-03-3107598573core:NetGoodwill2023-04-012024-03-3107598573core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107598573core:ListedExchangeTraded2023-04-012024-03-3107598573core:UnlistedNon-exchangeTraded2023-04-012024-03-3107598573core:MoreThanFiveYears2023-04-012024-03-3107598573core:Non-currentFinancialInstruments2024-03-3107598573core:Non-currentFinancialInstruments2023-03-3107598573dpl:CostSales2023-04-012024-03-3107598573dpl:DistributionCosts2023-04-012024-03-3107598573core:LandBuildings2023-04-012024-03-3107598573core:PlantMachinery2023-04-012024-03-3107598573core:Vehicles2023-04-012024-03-3107598573core:FurnitureFittings2023-04-012024-03-3107598573core:OfficeEquipment2023-04-012024-03-3107598573dpl:AdministrativeExpenses2023-04-012024-03-3107598573core:NetGoodwill2023-04-012024-03-3107598573core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107598573dpl:GroupUndertakings2023-04-012024-03-3107598573dpl:ParticipatingInterests2023-04-012024-03-3107598573dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3107598573core:ListedExchangeTraded2023-04-012024-03-3107598573dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3107598573core:UnlistedNon-exchangeTraded2023-04-012024-03-3107598573dpl:CostSales2022-04-012023-03-3107598573dpl:DistributionCosts2022-04-012023-03-3107598573core:LandBuildings2022-04-012023-03-3107598573core:PlantMachinery2022-04-012023-03-3107598573core:Vehicles2022-04-012023-03-3107598573core:FurnitureFittings2022-04-012023-03-3107598573core:OfficeEquipment2022-04-012023-03-3107598573dpl:AdministrativeExpenses2022-04-012023-03-3107598573core:NetGoodwill2022-04-012023-03-3107598573core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3107598573dpl:GroupUndertakings2022-04-012023-03-3107598573dpl:ParticipatingInterests2022-04-012023-03-3107598573dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3107598573core:ListedExchangeTraded2022-04-012023-03-3107598573dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3107598573core:UnlistedNon-exchangeTraded2022-04-012023-03-3107598573core:NetGoodwill2024-03-3107598573core:IntangibleAssetsOtherThanGoodwill2024-03-3107598573core:LandBuildings2024-03-3107598573core:PlantMachinery2024-03-3107598573core:Vehicles2024-03-3107598573core:FurnitureFittings2024-03-3107598573core:OfficeEquipment2024-03-3107598573core:AfterOneYear2024-03-3107598573core:WithinOneYear2024-03-3107598573core:ListedExchangeTraded2024-03-3107598573core:UnlistedNon-exchangeTraded2024-03-3107598573core:ShareCapital2024-03-3107598573core:SharePremium2024-03-3107598573core:RevaluationReserve2024-03-3107598573core:OtherReservesSubtotal2024-03-3107598573core:RetainedEarningsAccumulatedLosses2024-03-3107598573core:NetGoodwill2023-03-3107598573core:IntangibleAssetsOtherThanGoodwill2023-03-3107598573core:LandBuildings2023-03-3107598573core:PlantMachinery2023-03-3107598573core:Vehicles2023-03-3107598573core:FurnitureFittings2023-03-3107598573core:OfficeEquipment2023-03-3107598573core:AfterOneYear2023-03-3107598573core:WithinOneYear2023-03-3107598573core:ListedExchangeTraded2023-03-3107598573core:UnlistedNon-exchangeTraded2023-03-3107598573core:ShareCapital2023-03-3107598573core:SharePremium2023-03-3107598573core:RevaluationReserve2023-03-3107598573core:OtherReservesSubtotal2023-03-3107598573core:RetainedEarningsAccumulatedLosses2023-03-3107598573core:NetGoodwill2022-04-0107598573core:IntangibleAssetsOtherThanGoodwill2022-04-0107598573core:LandBuildings2022-04-0107598573core:PlantMachinery2022-04-0107598573core:Vehicles2022-04-0107598573core:FurnitureFittings2022-04-0107598573core:OfficeEquipment2022-04-0107598573core:AfterOneYear2022-04-0107598573core:WithinOneYear2022-04-0107598573core:ListedExchangeTraded2022-04-0107598573core:UnlistedNon-exchangeTraded2022-04-0107598573core:ShareCapital2022-04-0107598573core:SharePremium2022-04-0107598573core:RevaluationReserve2022-04-0107598573core:OtherReservesSubtotal2022-04-0107598573core:RetainedEarningsAccumulatedLosses2022-04-0107598573core:AfterOneYear2023-04-012024-03-3107598573core:WithinOneYear2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3107598573core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3107598573core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3107598573core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3107598573core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3107598573core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3107598573core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3107598573core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3107598573core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3107598573core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3107598573core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3107598573core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3107598573core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3107598573core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3107598573core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3107598573core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3107598573core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3107598573core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3107598573core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3107598573bus:Director12023-04-012024-03-3107598573bus:Director22023-04-012024-03-3107598573bus:Director32023-04-012024-03-31

EVERGREEN SURGERY LIMITED

Registered Number
07598573
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

EVERGREEN SURGERY LIMITED
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

ABEDI, Mohammed Khurram Ali, Dr
GREWAL, Harkirat
PATEL, Sanjay, Dr

Registered Address

Ramsay Brown Llp The Brentano Suite
Solar House, 915 High Road
North Finchley
N12 8QJ

Registered Number

07598573 (England and Wales)
EVERGREEN SURGERY LIMITED
Statement of Financial Position
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets323,31521,075
Investments49090
23,40521,165
Current assets
Debtors51,545,7582,054,407
Cash at bank and on hand275,064354,928
1,820,8222,409,335
Creditors amounts falling due within one year6(1,653,019)(2,313,108)
Net current assets (liabilities)167,80396,227
Total assets less current liabilities191,208117,392
Net assets191,208117,392
Capital and reserves
Called up share capital999999
Profit and loss account190,209116,393
Shareholders' funds191,208117,392
The financial statements were approved and authorised for issue by the Board of Directors on 7 November 2024, and are signed on its behalf by:
PATEL, Sanjay, Dr
Director
Registered Company No. 07598573
EVERGREEN SURGERY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Fixtures and fittings15-
Office Equipment-25
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Finance leases and hire purchase contracts
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.
2.Average number of employees

20242023
Average number of employees during the year132154
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 2369,445
Additions12,312
At 31 March 2481,757
Depreciation and impairment
At 01 April 2348,371
Charge for year10,070
Other adjustments1
At 31 March 2458,441
Net book value
At 31 March 2423,315
At 31 March 2321,075
4.Fixed asset investments

Total

£
Cost or valuation
At 01 April 2390
At 31 March 2490
Net book value
At 31 March 2490
At 31 March 2390
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables1,429,8602,053,408
Other debtors115,462999
Prepayments and accrued income436-
Total1,545,7582,054,407
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables1,623,8192,306,263
Taxation and social security16,5901,365
Accrued liabilities and deferred income12,6105,480
Total1,653,0192,313,108